Go to deals
Healthcare

VivaSon Group has sold a minority stake to Korian

Korian has acquired a minority stake in VivaSon Group.

Korian is a French company specialized in nursing home care for the elderly. Listed on Euronext Paris, Korian has nursing homes in France, Germany, Belgium, Italy, Spain and the Netherlands.

Founded in 2006, VivaSon is a family group dedicated to the distribution of auditory prostheses through a network of approximately 30 points of sale in France. The company had a turnover of US$18 million in 2020.

Oaklins’ team in France acted as buy-side advisor in this transaction.

Parties

Talk to the deal team

Arnaud Dubois

Senior Advisor
Lyon, France
Oaklins France

Related deals

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Healthcare

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval

Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.

Learn more
Rare Patient Voice has been acquired by Konovo
Healthcare | TMT

Rare Patient Voice has been acquired by Konovo

Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.

Learn more
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
Healthcare

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Learn more